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Abstract Matrix metalloproteinases (MMPs) are extra-
cellular zinc-dependent endopeptidases involved in the
degradation and remodelling of extracellular matrix in
physiological and pathological processes. MMPs also have
a role on cell proliferation, migration, differentiation,
angiogenesis and apoptosis. Umbilical cord is a special
organ subjected to many changes during pre-natal life and
whose cells can maintain a certain degree of plasticity also
in post-natal period; for example recently they have been
used as a source of stem cells. In this work we investigated
the expression of MMPs in human umbilical cord
and Human Umbilical Vein Endothelial Cells (HUVEC)
though immunohistochemistry, RT–PCR and gelatin
zymography. MMP-2 protein is expressed in the amniotic
epithelium of human umbilical cord and in few sub-epi-
thelial fibroblasts, while MMP-3 and MMP-10 only in the
umbilical epithelium. MMP-8, MMP-9 and MMP-13
immunoreactivity is localised in the epithelium and in
Wharton’s jelly mesenchymal cells. Immunocytochemistry
also revealed protein expression for MMP-2, 3, 8, 9 and 10
in cultured HUVEC. In agreement with immunohisto-
chemical data, RT–PCR analysis performed on samples of
whole umbilical cord confirmed the transcriptional
expression for the genes encoding all the six matrix
metalloproteinases investigated, while in HUVEC only the
expression of MMP-2, 3, 9, 10 and 13 mRNAs was
detected. Gelatin zymograpgy showed a clear MMP-2 and
MMP-9 enzymatic activity in the conditioned medium of
HUVEC at different culture passages, suggesting that
HUVEC secrete gelatinases, that afterwards undergo
extracellular activation, and this ability is not affected by
passage number.
Keywords Matrix metalloproteinases  Human
umbilical cord  HUVEC
Introduction
Matrix metalloproteinases (MMPs) are a family of extra-
cellular zinc-dependent neutral endopeptidases collectively
capable of degrading essentially all ExtraCellular Matrix
(ECM) components (Birkedal-Hansen et al. 1993). They
play an important role in ECM remodelling in physiolog-
ical processes, such as embryonal development, organ
morphogenesis, tissue regeneration, wound healing, nerve
growth, bone remodelling, angiogenesis and apoptosis.
MMPs also play a role in pathological conditions involving
accelerated turnover of ECM, for example rheumatoid
arthritis, osteoarthritis, periodontitis, chronic ulcerations,
cardiovascular disease, neurological disease, cirrhosis and
metastasis (Mandal et al. 2003; Lipari et al. 2009).
They are known to be involved in the cleavage of cell
surface receptors, the release of apoptotic ligands (such as
the FAS ligand) and chemokine inactivation. They are also
thought to play a major role in processes such as cell
proliferation, migration, differentiation, angiogenesis,
apoptosis and host defence (Nagase and Woessner 1999).
The most commonly used classification of matrix
metalloproteinases is based on substrate specificity and
cellular localization. They can be divided into secreted
MMPs and membrane-bound-MMPs (MT-MMPs). Secreted
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MMPs have been divided into collagenases (MMPs-1, 8 and
13), gelatinases (MMPs-2 and 9), stromelysins (MMPs-3, 10
and 11) and matrilysins (MMP-7 and 26). All MMPs share a
common structure with three conserved domains: (1) the pro-
domain (an autoinhibitory domain whose function is to
maintain the enzyme in the inactive form); (2) the catalytic
domain and (3) the C-terminal hemopexin-like domain.
MMP-2 and MMP-9 also have three repeats of fibronectin-
type II domain inserted in the catalytic domain, whose
function is to interact with collagens and gelatins (Nagase
and Woessner 1999; Morgunova et al. 1999; Trexler et al.
2003).
The activity of MMPs is controlled at many different
levels, including transcription, activation of zymogens and
interaction with specific inhibitors, firsts of all the Tissue
Inhibitors of MMPs (TIMPs) (Whatling et al. 2004).
Transcription of many MMPs genes is inducible: the
enhancers of MMPs genes transcription include growth
factors, cytokines, chemical agents, physical stresses,
oncogenic cellular transformation, etc…, while suppressive
factors are Transforming Growth Factor-b (TGF-b), reti-
noic acids and glucocorticoids (Nagase and Woessner
1999; Han et al. 2008; Jackson et al. 2009; Viappiani et al.
2009). All MMPs are synthesized as pre-pro-enzyme and
secreted as pro-enzyme (inactive form). Activation is
extracellular and requires the disruption of the ‘‘cysteine
switch’’ and the removal of the pro-peptide (Nagase and
Woessner 1999; Viappiani et al. 2009).
The umbilical cord is the organ connecting the foetus to
the placenta. Umbilical cord at term is made of three
vessels (two arteries coiled around a vein) surrounded by
the Wharton’s jelly, a soft connective tissue composed of
few mesenchymal stromal cells and abundant extracellular
matrix (Fig. 1) (Hoyes 1969; Parry and Abramovich 1972;
Meyer et al. 1983; Sobolewski et al. 1997; Can and Ka-
rahuseyinoglu 2007). Human umbilical cord is a special
organ subjected to many changes during pre-natal life and
whose cells can maintain a certain degree of plasticity also
in post-natal period; for example they have wide differ-
entiation potentiality (Karahuseyinoglu et al. 2007) and
recently have been used as a source of stem cells (Conconi
et al. 2006; Fu et al. 2004).
Human Umbilical Vein Endothelial Cells (HUVEC)
are highly dynamic cells: they show angiogenic ability
and actively participate to the regulation of vascular tone
through the production of vasoactive substances such as
eNOS, COX-1, COX-2 and cPLA2 (Gifford et al. 2004),
moreover they have shown to be endowed with an high
degree of plasticity; they have the potentiality to differ-
entiate into a wide range of different cell types, for
example neuron, smooth muscle cells and bone (Su et al.
2006; Krenning et al. 2008; Aguilar-Va´zquez et al.
2008).
In this work we investigated the expression of MMPs in
human umbilical cord and particularly in HUVEC, since
both of them are highly dynamic territories where these
enzymes, involved not only in ECM degradation but also in
processes such us cell proliferation, differentiation, angio-
genesis and surface molecule cleavage, could have an
important functional significance. The matrix metallopro-
teinases we investigated in this study are the gelatinases
MMP-2 and MMP-9, the collagenases MMP-8 and MMP-
13 and the stromelysin MMP-3 and MMP-10.
Materials and methods
Samples
The analysis was performed on 17 full-term human
umbilical cords obtained by caesarean section. The
umbilical cords were provided by the Gynecologic and
Obstetric clinic of the University Hospital ‘‘Paolo Giac-
cone’’ in Palermo. Informed consent was obtained from
patients few days before surgery. The experimentation was
approved by the ethics committee.
Immunohistochemistry
Human umbilical cords were collected in physiological
solution, one section (about 1 cm thick) was dissected from
each umbilical cord, formalin-fixed, dehydrated in a series
of alcohols, cleared in xylene and paraffin-embedded.
Sections of 7 lm were cut with a Leica microtome
Fig. 1 Azan staining of human umbilical cord at term. a amniotic
epithelium; b subamniotic Wharton’s jelly; c inner Wharton’s jelly;
d/e circular and longitudinal vascular musculature; f vascular endo-
thelium. Umbilical vein and arteries are indicated by the arrows
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RM2145, dried overnight at 37C and then stored at room
temperature until use; prior to immunostaining slides were
de-waxed in xylene, re-hydrated in a series of alcohols and
rinsed in distilled water for 5 min.
Immunohistochemistry was performed using the
‘‘DakoCytomation EnVision ? System-HRP (AEC)’’ kit
from Dako following manufacturer’s instructions: the sec-
tions of umbilical cord were covered with the ‘‘Peroxidase
block’’ reagent and incubated for 5 min at room temperature,
then rinsed once in Phosphate Buffer Saline (PBS) pH 7.2,
covered with the antibody solution and incubated at 4C
overnight. Mouse anti human MMP-2 monoclonal antibody
(Chemicon) (1:800 dilution), mouse anti MMP-3 monoclo-
nal antibody (Chemicon) (1:20), mouse anti human MMP-8
monoclonal antibody (Chemicon) (1:400), rabbit anti human
MMP-9 polyclonal antibody (DAKO) (1:100), mouse anti
human MMP-10 monoclonal antibody (Chemicon) (1:100)
and mouse anti MMP-13 monoclonal antibody (Chemicon)
(1:1000) were used. As negative controls for our antibodies
we used mouse IgG1 antibody (Dako, clone DAK-G01)
(1:100 dilution) and rabbit immunoglobulin fraction (Dako)
(1:200 dilution). All antibodies were diluted in a 0.1%
Bovine Serum Albumine (BSA) solution.
Samples were rinsed twice in PBS pH 7.2, incubated
with ‘‘Peroxidase Labelled Polymer’’ reagent for 30 min,
rinsed twice in PBS pH 7.2 and incubated with ‘‘Substrate-
Chromogen’’ reagent. The staining reaction was stopped
rinsing the slides in distilled water and staining time was
the same for all the samples. Slides were coverslipped
using the ‘‘DakoCytomation Faramount Aqueous Mount-
ing Medium’’ (Dako). The specimens were observed with a
Leica DM1000 light microscope.
Semi-quantitative evaluation of immunoreactivity
The intensity of immunostaining for the 6 Matrix
Metalloproteinases in our specimens was evaluated by
three independent observers. Score values were assigned
according to the following criteria: (-) no staining, (?)
light staining, (??) moderate staining, (???) intense
staining.
HUVEC isolation and culture
Human Umbilical Vein Endothelial cells (HUVEC) have
been isolated from full-term human umbilical cords obtained
from caesarean section immediately after the partum, and
stored in physiologic solution until isolation procedure.
Isolation of cells was performed within 3 h of tissue col-
lection. The method for HUVEC isolation is based on the
separation of endothelial cells from vein vessel wall using
collagenase digestion of the sub-endothelial basement
membrane, according to previously published methods
(Kumar et al. 2004; La Rocca et al. 2009) with slight mod-
ifications in the composition of culture and isolation media.
Briefly, umbilical cord vein was cannulated and perfused
with a heparin solution (50 U/ml), followed by Dulbecco
Phosphate Buffer Saline (DPBS) without Ca2? and
Mg2? (SIGMA) in order to remove blood residue from
vessel. The vein was perfused with collagenase solution
(Type II, GIBCO) 1 mg/ml and, after clamping of the ends,
the vein was filled with collagenase solution and incubated
for 15 min at 37C. Collagenase solution containing
HUVEC was collected in a sterile falcon tube, and the vein
was thoroughly flushed with isolation medium: M-199 sup-
plemented with antibiotic/antimycotic solution (SIGMA)
2X, in order to detach endothelial cells from vessel wall.
After centrifugation, cells were resuspended in complete
culture medium: M-199 supplemented with 10% FBS
(SIGMA), antibiotic/antimycotic solution (SIGMA) 1X,
0.1 mM L-glutamine, 20 lg/ml Endothelial Cell Growth
Factor (ECGF, Roche), 50 lg/ml heparin sodium salt
(SIGMA). Cells were seeded in gelatin-coated culture flasks
at a concentration of 30,000/cm2. Primary HUVEC were
used for experiments at passages 2–3.
Immunocytochemistry
HUVEC grown in chamber-slides (BD Falcon), were
washed with PBS and fixed with 4% paraphormaldeyde
for 15 min at room temperature, then washed again with
PBS. Slides were exposed to 0.3% H2O2 in H2O for
10 min and then washed with PBS. Slides were treated
with 1% BSA in PBS for 3 min, then incubated with the
primary antibody at 4C overnight. The following part of
the procedure was the same of the one previous described
for immunohistochemistry.
Total RNA extraction
Samples of human umbilical cord were frozen in liquid
nitrogen immediately after caesarean section and stored at
-80C until use. Cultured HUVEC were subjected to RNA
extraction immediately after the removal of culture med-
ium. Total RNA extraction was accomplished using the
‘‘illustra RNAspin Mini Kit’’ (Amersham Biosciences)
following manufacturer’s instructions. RNA yield was
evaluated spectrophotometrically (A260/A280) and RNA
aliquots were stored at -80C until use.
Reverse-transcription (RT)-polymerase chain reaction
(PCR)
For RT reaction 2 lg RNA was used. To avoid DNA
contamination of RNA samples DNAse digestion was
performed using ‘‘AMPD1 kit’’ (SIGMA). RT reaction was
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performed using the ‘‘Enhanced avian HS RT–PCR kit’’
(SIGMA) following manufacturer’s instructions. Briefly:
1 ll random nonamers and 1 ll anchored oligo (dT)23
were added to the DNAse digestion product and incubated
at 70C for 10 min to denature the sample. Then 2 ll 109
Buffer, 1 ll deoxynucleotide mix, 1 ll RNAse inhibitor,
1 ll Enhanced AMV Reverse Transcriptase enzyme and
DEPC water were added to the sample. RT reaction was
performed in 20 ll total volume at 42C for 50 min, fol-
lowed by a step at 95C for 5 min to inactivate the enzyme.
PCR reaction was performed as follow. 2 ll of DNA
(RT reaction product) was mixed with 18 ll distilled H2O,
2.5 ll gold buffer 10X, 0.75 mM MgCl2, deoxy-nucleo-
tides mix (dNTPs) 4 lM, primers mix 0.2 lM, Ampli Taq
Gold enzyme 1 U. The reaction was cycled for 9 min at
95C, then 40 cycles of 45 s 95C, 1 min 60C, and a final
extension step of 10 min at 60C. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) gene was used as
internal positive control. PCR products were visualized on
2% agarose gels, stained with sybr green (SIGMA).
Primers sequences are shown in Table 1.
Gelatin Zymography
HUVEC culture medium has been collected from different
passages (P1–P3), then dialyzed against Hepes 10 mM
solution, lyophilized and resuspended in distilled H2O.
Samples were separated on a 7.5% SDS–Polyacrylamide
gel containing 0.1% gelatine. For each sample 40 ug of
total protein was loaded. Human serum protein was used as
internal positive control. Following constant voltage elec-
trophoresis, gels were washed in renaturation buffer (2.5%
Triton X-100 in 50 mM Tris–HCl pH 7.5) for 1 h in an
orbital shaker. Then the zymograms were incubated for
18 h at 37C in incubation buffer (0.15 M NaCl, 10 mM
CaCl2, 0.02% NaN3 in 50 mM Tris–HCl pH 7.5). Gels
were then stained with Coomassie Brillant Blue and
destained with 7% methanol and 5% acetic acid solution.
Areas of enzymatic activity appeared as clear bands over
the dark background.
Semi-quantitative evaluation of lytic activity
Following zymography, the degree of gelatin digestion was
quantified using a scanner equipped with a transparency
adapter interfaced to an IBM PC. Gels were scanned using
1D ScanEX software, version 3.1 for Windows (Scanalyt-
ics), in a grey scale mode. The image was digitally inver-
ted, so that the integration of bands was reported as
positive values. The pixel density was determined after
background subtraction and used to calculate the integrated
density of a selected band. Values of integrated density
were reported in volume units of pixel intensity per mm2.
The integrated density of each band is reported as the mean
of three different measurements of the same band for each
sample run in triplicate. Moreover, for each experiment,
the intensity of each lytic band was measured three times in
order to exclude software-driven measurement errors.
Statistical analysis of data was performed by the chi-square
test, and P-value less than 0.05 was taken to be significant.
Results
MMPs protein expression in full-term human
umbilical cord
Immunohistochemistry showed an intense expression of
MMP-2 protein in the umbilical cord epithelial cells and in
Wharton’s jelly fibroblasts (Fig. 2a). The distribution of
Table 1 Name, nucleotide
sequence and length of the
amplification product for the
primers used in this work
GAPDH glyceraldehyde
3-phosphate dehydrogenase;
MMP matrix metallo proteinase;
G guanine; C cytosine;
A adenine; T timine
Primer name Primer sequence Amplification
product
GAPDH human forward GAG TCA ACG GAT TTG GTC GT 238 base pairs
GAPDH human reverse TTG ATT TTG GAG GGA TCT CG
MMP-2 human forward TGA TGG TGT CTG CTG GAA AG 280 base pairs
MMP-2 human reverse GAC ACG TGA AAA GTG CCT TG
MMP-3 human forward GCA GTT TGC TCA GCC TAT CC 214 base pairs
MMP-3 human reverse GAG TGT CGG AGT CCA GCT TC
MMP-8 human forward ATC TCA CAG GGA GAG GCA GA 372 base pairs
MMP-8 human reverse GCT TGG TCC AGT AGG TTG GA
MMP-9 human forward CAT TTC GAC GAT GAC GAG TTG 554 base pairs
MMP-9 human reverse AAG CCC CAC TTC TTG TCG CT
MMP-10 human forward GGC TCT TTC ACT CAG CCA AC 241 base pairs
MMP-10 human reverse TCT CCC CTC AGA GTG CTG AT
MMP-13 human forward GAC CCT GGA GCA CTC ATG TT 192 base pairs
MMP-13 human reverse TCC TCG GAG ACT GGT AAT GG
370 J Mol Hist (2010) 41:367–377
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positive cells in Wharton’s jelly did not appear homoge-
nous; the amount of fibroblasts expressing MMP-2 being
higher in the region immediately below the umbilical
epithelium and decreasing in the inner jelly towards blood
vessels.
MMP-3 protein expression was localized exclusively in
the umbilical cord epithelial cells (Fig. 2b) while all the
other umbilical cord regions were completely negative for
this enzyme. In the epithelium we observed a cytoplasmic
immunoreactivity in which the nucleus appeared clear
while the remaining part of the cell was filled with dark
brown staining granules. MMP-8 protein expression has
been identified in the amniotic epithelium (Fig. 2c), in the
stromal cells of Wharton’s jelly (Fig. 2d) and in some cells
of the blood vessel musculature. Immunoreactivity is
intense on the epithelium, while in Wharton’s jelly and in
vessel musculature MMP-8 protein expression appears
moderate.
MMP-9 immunostaining is intense with well defined
edges. Protein expression was localized in the umbilical
cord epithelial cells and in Wharton’s jelly fibroblasts and
mesenchymal cells (Fig. 2e). We also detected a staining of
the musculature around blood vessels which appears uni-
form and diffuse so that we believe it is a poorly specific
labelling (data not shown). MMP-10 protein expression
was clearly identified only in epithelial cells (Fig. 2f); all
the other umbilical cord regions did not show an evident
immunostaining for this protein, we could detect just a
faint reactivity in some of Wharton’s jelly cells.
MMP-13 immunoreactivity was localized in the umbil-
ical cord epithelium, in Wharton’s jelly fibroblasts and
mesenchymal cells (Fig. 2g), and showed a diffuse but
intense staining also in the cells of the muscular layers
around blood vessels (Fig. 2h). In the epithelial cells the
immunostaining was cytoplasmic, intense and well-
defined, thus making evident the boundary between the
cells and between the nucleus and the cytoplasm.
MMPs gene expression in full-term human
umbilical cord
RT–PCR analysis performed on the whole umbilical cord
was in agreement with immunohistochemical data showing
transcriptional expression of the genes encoding for all the
six matrix metalloproteinases investigated. Figure 3 shows
DNA bands corresponding to the specific amplification
products for the six genes.
MMPs protein expression in HUVEC
Immunocytochemistry showed MMP-2 protein expression
in HUVEC. All the cultured cells were positive for this
enzyme. Immunostaining was cytoplasmic and intense on a
very clear background (Fig. 4a), moreover the single dark
brown staining granules could be distinguished around the
nucleus and in cell processes. MMP-3 immunoreactivity is
evident in all the cultured HUVEC; the reactivity is clearly
cytoplasmic, mainly located around the nucleus and also
evident in the cytoplasmic processes of the cell (Fig. 4b, c).
The immunostaining appeared as single granules filling the
cytoplasm of the cells.
A strong cytoplasmic MMP-8 protein expression was
identified in all the cultured cells (Fig. 4d). By immuno-
histochemistry we detected MMP-9 protein expression in
HUVEC, even if the immunoreactivity appeared moderate
compared to the other MMPs tested (Fig. 4e). MMP-10
immunoreactivity was identified in all the cultured cells, it
was an intense reactivity, localized into the cytoplasm, and
appeared as condensed in dark brown granules (Fig. 3f).
Immunocytochemistry did not detect any protein expres-
sion for MMP-13 in HUVEC (data not shown).
MMPs gene expression in HUVEC
The results of RT–PCR analysis performed on cultured
HUVEC confirmed immunocytochemical findings and
revealed the transcriptional expression of the genes
encoding for MMP-2, MMP-3, MMP-9, MMP-10 and
MMP-13, while MMP-8 gene expression was not detected;
Fig. 5 shows DNA bands corresponding to the specific
amplification products for all the genes investigated but
MMP-8.
Gelatinolytic activity of secreted gelatinases
Immunocytochemistry provided information only on the
presence of MMPs proteins, without distinguish between
the inactive pro-enzyme and the cleaved, activated enzyme.
We decided to investigate the presence of MMPs
enzymatic activity and, since MMPs are secreted proteins
whose activation takes place in the extracellular environ-
ment, we searched for this activity in the conditioned
medium of HUVEC. We tested the enzymatic activity of
MMP-2 and MMP-9 secreted by HUVEC through gelatin
zymograpgy assay. Moreover, the analysis has been per-
formed on the conditioned medium harvested from HU-
VEC at different culture passages to determine if cellular
senescence affects either the ability of HUVEC to syn-
thesize and secrete MMP-2 and MMP-9 or the extracellular
activation of these enzymes.
Zymography showed that the level of MMP-2 enzymatic
activity did not vary significantly from passage 1 to
passage 3 (P [ 0.05). The same pattern was showed by
MMP-9 (P [ 0.05) (Fig. 6). In all the samples (P1, P2, P3)
gelatinolytic activity of MMP-2 was higher than MMP-9
and the difference was statistically significant (P \ 0.05).
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Chart 1 represents a semi-quantitative analysis of MMP-9
and MMP-2 gelatinolytic activity. Data represented are
means of three replicated experiments, with the indication
of the standard deviation.
Discussion
We investigated, through immunohistochemistry, the
expression and localization of six matrix metalloprotein-
ases in the different regions of full-term human umbilical
cord (Table 2).
We detected the expression of gelatinases (gelatinase-A
and B; MMP-2 and MMP-9) in the cells of umbilical
epithelium and Wharton’s jelly. These data are in agree-
ment with previous studies reported in literature; Sobo-
lewski et al. (2001) found the expression of MMP-2 and 9
in Wharton’s jelly cells and they made the hypothesis that
an alteration in the expression, or activity, of these
enzymes could be related to the development of Oedema/
proteinuria/hypertension (EPH) gestosis.
We also detected the presence of stromelysins (strom-
elysin-1 and -2; MMP-3 and MMP-10) only in epithelial
cells of umbilical cord. The expression of MMP-3 and
MMP-10 in epithelial cells both in normal and pathological
tissue remodelling has been reported by many authors and
some of them related stromelysins expression to processes
such as wound healing, cell migration and tumor devel-
opment (Daniels et al. 2003; Krampert et al. 2004;
McCawley et al. 2008).
Our experiments showed expression of collagenases
(collagenase-1 and 2; MMP-8 and MMP-13) in umbilical
cord epithelium, in Wharton’s jelly cells and in blood
vessel musculature.
After we detected protein expression and spatial distri-
bution of these six matrix metalloproteinases in human
umbilical cord, we wanted to investigate transcriptional
expression of the genes encoding for these enzymes, thus
we performed RT–PCR analysis on total RNA extracted
from human umbilical cords. The analysis confirmed the
transcriptional expression of the genes encoding for all the
six matrix metalloproteinases tested.
In the continuation of our study we focused our attention
on the expression of these six proteases in HUVEC isolated
from umbilical cord. These cells have shown to be
endowed with an high degree of plasticity; they have the
potentiality to differentiate into different cell types, for
example neuron-like cells (Su et al. 2006), vascular smooth
muscle cells (Krenning et al. 2008) and osteogenic ligneage
(Aguilar-Va´zquez et al. 2008). The presence of HUVEC in
co-culture with other cell type can affect the differentiation
and/or the proliferation rates of both cell types (Hofmann
et al. 2008; Lai et al. 2009). They also have a role in the
stimulation/regulation of the activity of the hematopoietic
progenitor cells (Yamaguchi et al. 1998). HUVEC are also
known to actively participate in angiogenesis and vascular
tone modulation through the production of vasoactive
substances; under this point of view they can be considered
one of the umbilical cord cell types more dynamic and for
this reason we thought it was interesting to deepen our
research investigating the expression of MMPs in these
cells.
Immunocytochemistry showed the expression of MMP-
2, 3, 8, 9 and10 in all cultured HUVEC, while MMP-13
protein was not detected. The results of RT–PCR analysis
performed on HUVEC revealed the transcriptional
expression of the genes encoding for MMP-2, 3, 9, 10 and
13, while MMP-8 gene is not expressed.
In HUVEC we detected MMP-13 mRNA but we did not
find the protein. This could be due to a low MMP-13
protein synthesis or to the possibility that the protein, after
being synthesized, is secreted into the extracellular envi-
ronment where it exerts its function.
The expression of MMP-8 protein and mRNA seems
conflicting; we evidenced the presence of MMP-8 protein
through immunohistochemistry but we did not detect the
mRNA through RT–PCR; it is possible that the level of
Fig. 3 Representative picture of RT–PCR analysis performed on
human umbilical cord. Amplification products for; lane 1: GAPDH
(232 bp); lane 2: MMP-2 (280 bp); lane 3: MMP-3 (214 bp); lane 4:
MMP-8 (372 bp); lane 5: MMP-9 (554 bp); lane 6: MMP-10
(241 bp); lane 7: MMP-13 (192 bp); lane 8: 100 bp DNA ladder
Fig. 2 Immunohistochemistry on human umbilical cord sections.
a MMP-2 in the umbilical epithelium and in the cells of the
Wharton’s jelly (40X); b MMP-3 in the epithelium (40X); c MMP-8
in the epithelium (40X); d faint MMP-8 expression in Wharton’s jelly
cells (100X); e MMP-9 in the epithelium and in the cells of the
Wharton’s jelly (100X); f MMP-10 in the amniotic epithelium (40X);
g MMP-13 in the epithelium and few fibroblasts (40X); h MMP-13 in
cells of the vessel musculature (40X)
b
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expression of MMP-8 mRNA is below the sensitivity of the
technique we used.
The fact we detected the expression of almost all MMPs
in cultured HUVEC while none of them in the endothelium
of whole umbilical cord could be explained considering
that blood vessel endothelium is a very delicate structure
that can be easily damaged during fixation/embedding
procedures needed for immunohistochemistry.
The antibodies used for immunohistochemistry were not
able to distinguish between the active and the inactive form
Fig. 4 Immunohistochemistry on cultured HUVEC. a cytoplasmic
immunoreactivity for MMP-2 in HUVEC (100X); b MMP-3 expres-
sion in all the cultured cells (20X); c MMP-3 expression in the
cytoplasm and in the processes of HUVEC, the single staining
granules can be distinguished (100X); d MMP-8 staining in
cytoplasm and cell processes (100X); e MMP-9 expression in the
cytoplasm of all cultured cells (100X); f MMP-10 expression in
HUVEC (100X)
374 J Mol Hist (2010) 41:367–377
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of the metalloproteinases investigated, so this experiment
could give information only on the presence of proteins and
not on their enzymatic activity. On the contrary, gelatin
zymography allows to study the entity of MMP-2 and
MMP-9 gelatin degrading activity. The result of the assay,
performed on HUVEC conditioned medium, showed
HUVEC ability to produce and secrete sensible amount of
pro-gelatinases and that these pro-enzymes are efficiently
activated in the extracellular environment. Moreover,
zymography has been performed on the conditioned med-
ium harvested from HUVEC at different culture passages
to determine if cellular senescence affects either the ability
of HUVEC to synthesize and secrete MMP-2 and MMP-9
or the extracellular activation of these enzymes. No sig-
nificant difference has been found between the gelatino-
lytic activity of MMP-2 and MMP-9 in HUVEC
conditioned medium from passages 1–3, thus senescence
seems not to influence this aspect. The choice to use very
close passage number (passages 1–3) was forced by the
fact that HUVEC are primary cells with a very fast
senescence process that, among the others typical features
Fig. 5 Representative picture of RT–PCR analysis performed on
cultured HUVEC. Lane 1: MMP-2 amplification product (280 bp);
lane 2: MMP-3 amplification product (214 bp); lane 3: no amplifi-
cation product for MMP-8; lane 4: MMP-9 amplification product
(554 bp); lane 5: MMP-10 amplification product (241 bp); lane 6:
MMP-13 amplification product (192 bp); lane 7: GAPDH amplifica-
tion product (232 bp); lane 8: 100 bp DNA ladder
Fig. 6 Representative picture of gelatin zymography assay per-
formed on HUVEC conditioned medium at different culture passage.
Bands corresponding to MMP-9 (92 KDa) and MMP-2 (72 KDA) are
indicated by the arrows and visible in all samples. Lane 1: human
serum; lane 2: passage 1 (P1); lane 3: passage 2 (P2); lane 4: passage
3 (P3)
Chart 1 Semi-quantitative analysis of MMP-9 and MMP-2 gelatin-
olytic activity in HUVEC conditioned medium at different passage
number (P1-P3). Bars represents the mean standard deviation
Table 2 Summary of immunohistochemical results in the different regions of human umbilical cord
Epithelium Wharton’s jelly Vessel musculature Endothelium
MMP-2 (gelatinase-A) ??? ??? - -
MMP-9 (gelatinase-B) ??? ??? - -
MMP-8 (collagenase-2) ??? ? ? -
MMP-13 (collagenase-3) ??? ?? ?? -
MMP-3 (stromelysin-1) ??? - - -
MMP-10 (stromelysin-2) ?? - - -
Score values (from - to ???) have been assigned by three independent operators
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of senescence, implies growth delay and survival decrease,
thus even cells at passage 4 appear unhealthy and not suitable
for experiments.
This work makes light on the pattern of expression and
distribution of several types of matrix metalloproteinases
(gelatinases, collagenases and stromelysins) in the dif-
ferent regions of full-term human umbilical cord and
in cultured HUVEC. The expression of the six matrix
metalloproteinases we investigated is evident in almost all
the regions of human umbilical cord at term. The mean-
ing of the wide distribution of these enzymes in this organ
has to be linked to their role in the degradation and
remodelling of extracellular matrix and in other physio-
logical processes such as cell proliferation, differentiation
and apoptosis. These data could be useful in the com-
prehension of MMPs distribution and activity in this and
other tissues in physiological and pathological conditions.
It would be interesting to enrich this work with the study
of all the other types of MMPs.
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